News and ViewsStrong Relative Performance Against Benchmarks
Over the past week, Sakar Healthcare has outpaced the Sensex by a considerable margin, delivering a 9.39% gain compared to the benchmark’s decline of 0.52%. This outperformance extends over longer periods as well, with the stock appreciating 4.21% in the last month against the Sensex’s modest 0.79% rise. Year-to-date, the stock has surged 42.27%, vastly outperforming the Sensex’s 9.53% gain. Even over one, three, and five-year horizons, Sakar Healthcare’s returns of 31.00%, 77.24%, and 339.32% respectively, have comfortably exceeded the benchmark’s corresponding returns of 5.10%, 40.02%, and 91.64%. These figures highlight the stock’s consistent ability to generate superior returns, attracting investor interest and driving price ...
Read More
